Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Shares Rise 32 Percent

Shares of Sequenom rose 32 percent for the five-day trading week ended Tuesday to lead all stocks in the BCW Index.
 
The gain follows last week’s increase of 23 percent for Sequenom. Last week, the company announced that it had licensed a next-generation sequencing technology from Harvard University.
 
Shares of Cepheid and Bio-Rad Laboratories also had strong weeks, rising 13.5 percent and 13.3 percent, respectively.
 
Third Wave Technologies led decliners for the tracking period with a drop of 2.5 percent.
 
Overall, the Index was up 2.4 percent. In comparison, the Dow Jones Industrial Average increased 1.9 percent, the Nasdaq gained 2.4 percent, and the Nasdaq Biotech Index climbed 2 percent.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(Oct. 2, 2007)
Starting Price
(
Sept. 25, 2007)
% change
Affymetrix
AFFX
26.21
24.74
5.94
Agilent
A
37
36.77
0.63
Applied Biosystems
ABI
34.41
34.27
0.41
Beckman
BEC
73
72.76
0.33
Becton Dickinson
BDX
82.86
81.98
1.07
Bio-Rad
BIO
94.6
83.5
13.29
Bruker
BRKR
8.71
8.87
-1.80
Caliper
CALP
5.57
5.59
-0.36
Cepheid
CPHD
24.1
21.24
13.47
Illumina
ILMN
52.94
52.46
0.91
Invitrogen
IVGN
82.36
83.27
-1.09
Luminex
LMNX
16.5
15.71
5.03
MDS
MDZ
21.06
21.14
-0.38
Millipore
MIL
75.24
76.1
-1.13
PerkinElmer
PKI
28.91
28.49
1.47
Qiagen
QGEN
19.5
18.18
7.26
Sequenom
SQNM
8.12
6.15
32.03
Sigma-Aldrich
SIAL
48.78
47.85
1.94
Thermo
TMO
57.32
57.2
0.21
Third Wave
TWTI
8.87
9.1
-2.53
Waters
WAT
67
67.28
-0.42
BCW Index Average  
41.57
40.60
2.39
The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.